Lanean...
Heterologous vaccination and checkpoint blockade synergize to induce anti-leukemia immunity
Checkpoint blockade-based immunotherapies are effective in cancers with high numbers of non-synonymous mutations. In contrast, current paradigms suggest that such approaches will be ineffective in cancers with few non-synonymous mutations. To examine this issue we made use of a murine model of BCR-A...
Gorde:
| Argitaratua izan da: | J Immunol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4875863/ https://ncbi.nlm.nih.gov/pubmed/27183622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1600130 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|